 Eligibility Determination
"Eligibility Determination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Criteria to determine eligibility of patients for medical care programs and services.
| Descriptor ID |
D004608
|
| MeSH Number(s) |
N04.452.264
|
| Concept/Terms |
Eligibility Determination- Eligibility Determination
- Determination, Eligibility
- Determinations, Eligibility
- Eligibility Determinations
Eligibility Certification- Eligibility Certification
- Certification, Eligibility
- Certifications, Eligibility
- Eligibility Certifications
|
Below are MeSH descriptors whose meaning is more general than "Eligibility Determination".
Below are MeSH descriptors whose meaning is more specific than "Eligibility Determination".
This graph shows the total number of publications written about "Eligibility Determination" by people in this website by year, and whether "Eligibility Determination" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 1 | 2 | | 2003 | 0 | 1 | 1 | | 2004 | 0 | 2 | 2 | | 2007 | 0 | 1 | 1 | | 2008 | 1 | 3 | 4 | | 2009 | 1 | 2 | 3 | | 2010 | 1 | 0 | 1 | | 2011 | 0 | 1 | 1 | | 2012 | 1 | 0 | 1 | | 2013 | 1 | 1 | 2 | | 2014 | 1 | 0 | 1 | | 2015 | 1 | 0 | 1 | | 2016 | 0 | 3 | 3 | | 2017 | 0 | 4 | 4 | | 2018 | 1 | 1 | 2 | | 2019 | 2 | 2 | 4 | | 2020 | 4 | 1 | 5 | | 2021 | 2 | 0 | 2 | | 2023 | 0 | 3 | 3 | | 2024 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Eligibility Determination" by people in Profiles.
-
Cholin LK, Ramos EF, Yahr J, Schold JD, Poggio ED, Delvalle CL, Huml AM. Psychosocial characteristics of potential and actual living kidney donors. BMC Nephrol. 2024 Jan 24; 25(1):31.
-
Marks SJ, Davoodi NM, Felton R, Rothberg A, Goldberg EM. The Effect of COVID-19 on Dual-Eligible Beneficiaries: A Scoping Review. J Am Med Dir Assoc. 2023 10; 24(10):1565-1572.
-
Kaskovich S, Wyatt KD, Oliwa T, Graglia L, Furner B, Lee J, Mayampurath A, Volchenboum SL. Automated Matching of Patients to Clinical Trials: A Patient-Centric Natural Language Processing Approach for Pediatric Leukemia. JCO Clin Cancer Inform. 2023 07; 7:e2300009.
-
Summers Holtrop J, Kramer E, Gritz M, Suresh K, Perreault L, Dickinson LM, Tolle L, Williams J, Smith P. Baseline Characteristics of PATHWEIGH: A Stepped-Wedge Cluster Randomized Study for Weight Management in Primary Care. Ann Fam Med. 2023 Jan 01; 21(Suppl 1).
-
Coburn SB, Lang R, Zhang J, Palella FJ, Horberg MA, Castillo-Mancilla J, Gebo K, Galaviz KI, Gill MJ, Silverberg MJ, Hulgan T, Elion RA, Justice AC, Moore RD, Althoff KN. Statins Utilization in Adults With HIV: The Treatment Gap and Predictors of Statin Initiation. J Acquir Immune Defic Syndr. 2022 12 15; 91(5):469-478.
-
Bahiru E, Ziaeian B, Moucheraud C, Agarwal A, Xu H, Matsouaka RA, DeVore AD, Heidenreich PA, Allen LA, Yancy CW, Fonarow GC. Association of Dual Eligibility for Medicare and Medicaid With Heart Failure Quality and Outcomes Among Get With The Guidelines-Heart Failure Hospitals. JAMA Cardiol. 2021 07 01; 6(7):791-800.
-
Panthofer AM, Olson SL, Rademacher BL, Grudzinski JK, Chaikof EL, Matsumura JS. Anatomic eligibility for endovascular aneurysm repair preserved over 2?years of surveillance. J Vasc Surg. 2021 11; 74(5):1527-1536.e1.
-
Dempsey AG, Goode RH, Colon MT, Holubeck P, Nsier H, Zopatti K, Needelman H. Variations in Criteria for Eligibility Determination for Early Intervention Services with a Focus on Eligibility for Children with Neonatal Complications. J Dev Behav Pediatr. 2020 Oct-Nov; 41(8):646-655.
-
Gidwani-Marszowski R, Boothroyd D, Needleman J, Illarmo S, Asch SM. Comorbidity Assessment Is Uneven Across Veterans Health Administration and Medicare for the Same Patient: Implications for Risk Adjustment. Med Care. 2020 08; 58(8):717-721.
-
Kanni T, Argyropoulou M, Dinarello CA, Simard J, Giamarellos-Bourboulis EJ. MABp1 targeting interleukin-1a in hidradenitis suppurativa ineligible for adalimumab treatment: results of the open-label extension period. Clin Exp Dermatol. 2021 Jan; 46(1):162-163.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|